Acer Therapeutics Highlights Key 2022 Achievements and : vim

NEWTON, Mass., Jan. 09, 2023 (GLOBE NEWSWIRE) -- NEWTON, MA – January 09, 2023 – Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company...

Related Keywords

Jim Denike , Chris Schelling , Nick Colangelo , National Center , Emory University , Drug Administration , Us Department Of Defense Do , Nasdaq , Exchange Commission , Development Milestones Subject To Available Capital , Gilmartin Group , University Of Kansas Cancer Center , Acer Therapeutics Inc , Acer Therapeutics , Vasomotor Symptoms , Post Traumatic Stress Disorder , Ehlers Danlos Syndrome , Important Safety Information , Prescribing Information , Patient Information , North Carolina Institute , Trauma Recovery , Hot Flashes , Reduce Testosterone , Kansas Cancer Center , Available Capital , Maple Syrup Urine Disease , Pyruvate Dehydrogenase Complex Deficiency , Show Common , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Nasdaq Acer ,